Entrada Therapeutics Cost of Goods Sold 2020-2025 | TRDA
Entrada Therapeutics cost of goods sold from 2020 to 2025. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.